Literature DB >> 8953610

NCCN Ovarian Cancer Practice Guidelines. The National Comprehensive Cancer Network.

R J Morgan1, L Copeland, D Gershenson, G Locker, D McIntosh, R Ozols, N Teng.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8953610

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  9 in total

1.  The value of abdominal CT scans in decision-making during chemotherapy in ovarian cancer.

Authors:  M A L van Lankveld; P H M Peeters; M A van Eijkeren; V C M Koot; P O Witteveen; W P Th M Mali
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

Review 2.  Gynecologic biopsy for molecular profiling: a review for the interventional radiologist.

Authors:  Bradley R Corr; Kian Behbakht; Monique A Spillman
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

3.  Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.

Authors:  Wei Lin; Dongyan Cao; Xiaohua Shi; Yan You; Jiaxin Yang; Keng Shen
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

4.  CUB and zona pellucida-like domain-containing protein 1 (CUZD1): a novel serological biomarker for ovarian cancer.

Authors:  F Leung; A Soosaipillai; V Kulasingam; E P Diamandis
Journal:  Clin Biochem       Date:  2012-08-17       Impact factor: 3.281

5.  Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996-2014.

Authors:  Carolina Villanueva; Jenny Chang; Argyrios Ziogas; Robert E Bristow; Verónica M Vieira
Journal:  Cancer Epidemiol       Date:  2020-10-03       Impact factor: 2.984

6.  Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.

Authors:  Qing Liu; Da-Wo Liu; Ming-Jun Zheng; Lu Deng; Hui-Min Wang; Shan Jin; Juan-Juan Liu; Ying-Ying Hao; Lian-Cheng Zhu; Bei Lin
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

Review 7.  BRCA mutations in the manifestation and treatment of ovarian cancer.

Authors:  Zimin Pan; Xing Xie
Journal:  Oncotarget       Date:  2017-05-30

8.  Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study.

Authors:  Wei Lin; Dongyan Cao; Keng Shen
Journal:  Cancer Manag Res       Date:  2018-12-13       Impact factor: 3.989

9.  Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer.

Authors:  Nicholas Cardillo; Eric J Devor; Silvana Pedra Nobre; Andreea Newtson; Kimberly Leslie; David P Bender; Brian J Smith; Michael J Goodheart; Jesus Gonzalez-Bosquet
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.